NEI Research News

Researchers have discovered a connection between levels of specific proteins in patients’ tears and persistent pain months after surgery such as LASIK.

Researchers have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people preserve their central vision.

Scientists from around the world gathered recently in Seattle, Washington, at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) to address the global increase in myopia (nearsightedness).

Researchers at the University of Oklahoma Health Sciences and Memorial Sloan Kettering (MSK) Cancer Center are studying a new, revolutionary treatment for diabetic retinopathy that could change the prognosis for these patients.

At a fraction of the cost, biosimilars are now proven to be as effective as original anti-VEGF medications.

Perspective article aims to help beginning scientists develop thoughtful, articulate, compelling, and competitive research proposals.

About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness.

The National Eye Institute has worked with the editors-in-chief of 7 leading vision journals to create a new two-year program: the Council of Vision Editors Fellowship Program.

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study.

Variant of ALG6 delays rod photoreceptor degradation but decreases cone health in people with RP59 retinitis pigmentosa, according to a new study from University of Alabama, Birmingham.